Although the findings are very important to relate α7nAChR to the progression of NAFLD and insulin resistance, the effects described may have arisen from α7nAChR located in hepatocytes or macrophages for example. This evidence concerns the gene CHRNA7 and metabolic dysfunction-associated steatotic liver disease.